Macromolecular Research

The Polymer Society of Korea (한국고분자학회)
권호 표지

Preparation and Characterization of Folic Acid Linked Poly(L-glutamate) Nanoparticles for Cancer Targeting

  • Lee Yong-Kyu (Department of Chemical and Biological Engineering, Chungju National University)
  • Published : 2006.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Nanoparticles of Poly(L-glutamic acid) (PG) conjugated to the anticancer drug paclitaxel and targeted moiety folic acid (FA) were synthesized and characterized in vitro. The nanoparticles were designed to take advantage of FA targeting to folate receptor (FR) positive cancer cells. The chemical composition of the conjugate was characterized by $^1H-NMR$, FTIR and UV/vis spectroscopy. The selective cytotoxicity of the FA-PG-paclitaxel conjugates was evaluated in FR positive cancer cells. The interaction of the conjugate was visualized by fluorescence microscopy with results confirming the successful preparation of the conjugate and the production of nanoparticles of about 200-300 nm in diameter. The amount of paclitaxel conjugated to FA-PG was 25% by weight. Cellular uptake of the conjugate was FA dependent, and the conjugate uptake was mediated specifically by the folate receptor. These results demonstrate the improved selective toxicity and effective delivery of an anticancer drug into FR bearing cells in vitro.

Keywords

References

  1. J. B. Gibbs, Science, 287, 1969 (2000) https://doi.org/10.1126/science.287.5460.1969
  2. D. Dube, M. Francis, J.-C. Leroux, and F. M. Winnik, Bioconjugate Chem., 13, 685 (2002) https://doi.org/10.1021/bc010084g
  3. J. Sudimack and R. J. Lee, Adv. Drug Del. Rev., 41, 147 (2000) https://doi.org/10.1016/S0169-409X(99)00062-9
  4. A. Tang, P. Kopeckova, and J. Kopecek, Pharm. Res., 20, 360 (2003) https://doi.org/10.1023/A:1022639701388
  5. M. V. Backer and J. M. Backer, Bioconjugate Chem., 12, 1066 (2001) https://doi.org/10.1021/bc015534j
  6. N. K. Egilmez, Y. S. Jong, M. S. Sabel, J. S. Jacob, E. Mathiowitz, and R. B. Bankert, Cancer Res., 60, 3832 (2000)
  7. C. J. Mathias, D. Hubers, P. S. Low, and M. A.Green, Bioconjugate Chem., 11, 253 (2000) https://doi.org/10.1021/bc9901447
  8. G. F. Rowland, G. J. O'Neill, and D. A. L. Davies, Nature, 255, 487 (1975) https://doi.org/10.1038/255487a0
  9. J. Vega, S. Ke, Z. Fan, S. Wallace, C. Charsangave, and C. Li, Pharm. Res., 20, 826 (2003) https://doi.org/10.1023/A:1023454107190
  10. P. Caliceti, S. Salmaso, A. Semenzato, T. Carofiglio, R. Fornasier, M. Fermeglia, M. Ferrone, and S. Pricl, Bioconjugate Chem., 14, 899 (2003) https://doi.org/10.1021/bc034080i
  11. S. Wang, R. J. Lee, C. J. Mathias, M. A. Green, and P. S. Low, Bioconjugate Chem., 7, 56 (1996) https://doi.org/10.1021/bc9500709
  12. K. Y. Lee, Macromol. Res., 13, 542 (2005) https://doi.org/10.1007/BF03218494
  13. L. L. Kiessling, J. E.Gestwicki, and L. E. Strong, Curr. Opin. Chem. Biol., 4, 696 (2000) https://doi.org/10.1016/S1367-5931(00)00153-8
  14. M. Mammen, S.-K.Choi, and G. M. Whitesides, Angew. Chem. Int. Ed. Engl., 37, 2754 (1998) https://doi.org/10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
  15. D. M. Spencer, T. J. Wandless, S. L. Schreiber, and G. R. Crabtree, Science, 262, 1019 (1993) https://doi.org/10.1126/science.7694365
  16. C. R. Thomas and P. Bonomi, Curr. Opin. Oncol., 2, 359 (1990) https://doi.org/10.1097/00001622-199004000-00019
  17. R. Komaki, J. B. Putnam, and J. D. Shin Cox, Curr. Opin. Oncol., 9, 156 (1997) https://doi.org/10.1097/00001622-199703000-00009
  18. C. Li, Adv. Drug. Deliv. Rev., 54, 695 (2002) https://doi.org/10.1016/S0169-409X(02)00045-5
  19. C. Li, J. E. Price, L. Milas, N. R. Hunter, S. Ke, D.-F. Yu, C. Charnsangavej, and S. Wallace, Clin. Cancer Res., 5, 891 (1999)
  20. R. Duncan, Nature Rev. Drug Discov., 2, 347 (2003) https://doi.org/10.1038/nrd1088
  21. W. Tansey, S. Ke, X.-Y. Cao, M. J. Pasuelo, S. Wallace, and C. Li, J. Control. Release, 94, 39 (2004) https://doi.org/10.1016/j.jconrel.2003.09.005
  22. T. J. Deming, Nature, 390, 386 (1997) https://doi.org/10.1038/37084
  23. C. Li, D. F. Yu, R. A. Newman, F. Cabral, L. C. Stephens, N. Hunter, L. Milas, and S. Wallace, Cancer Res., 58, 2404 (1998)
  24. C. P. Leamon, S. R. Cooper, and G. E. Hardee, Bioconjugate Chem., 14, 738 (2003) https://doi.org/10.1021/bc020089t